TY - JOUR
T1 - The prognosis of elderly patients with aortic stenosis after transcatheter aortic valve replacement
AU - Saito, Yukihiro
AU - Lewis, Erik E.
AU - Raval, Amish
AU - Gimelli, Giorgio
AU - Jacobson, Kurt M.
AU - Osaki, Satoru
N1 - Publisher Copyright:
© 2021 Japanese Society of Internal Medicine. All rights reserved.
PY - 2021/2/15
Y1 - 2021/2/15
N2 - Objective Aortic stenosis (AS) is common among elderly patients. Since transcatheter aortic valve replacement (TAVR) is a less invasive procedure than surgical aortic valve replacement for symptomatic severe AS, super-elderly patients have tended to undergo TAVR. We retrospectively investigated the post-TAVR outcome in super-elderly patients with severe AS. Methods This analysis included 433 patients who underwent TAVR in the University of Wisconsin Hospital and Clinics from 2012 to 2017. Post-TAVR mortality, complications in-hospital, rehospitalization, the New York Heart Association (NYHA) functional class and echocardiographic parameters were compared between patients <85 years old (n = 290) and _85 years old (n = 143). Results The patients _85 years old less frequently had a history of coronary artery disease (73.1% vs. 62.2%, p=0.026) and hypertension (87.2% vs. 77.6%, p=0.012) than younger patients. Furthermore, the patients _85 years old had moderate-severe mitral regurgitation more frequently (19.3% vs. 28.7%, p=0.037) at baseline than younger patients. There was no significant difference in in-hospital outcomes between the age groups. The 30-day mortality was worse in patients _85 years old than in younger ones (0.7% vs. 3.5%, p= 0.042). While there was no significant difference in the long-term mortality between the 2 groups, the estimated 1-year mortality from Kaplan-Meier curves were 9.6% in patients <85 years old and 14.9% in patients _85 years old. The rate of in-hospital complications, rehospitalization rate, improvement in the NYHA functional class and echocardiographic parameters were comparable between the two groups. Conclusion The outcomes of super-elderly patients after TAVR were acceptable, suggesting that these patients could benefit from TAVR.
AB - Objective Aortic stenosis (AS) is common among elderly patients. Since transcatheter aortic valve replacement (TAVR) is a less invasive procedure than surgical aortic valve replacement for symptomatic severe AS, super-elderly patients have tended to undergo TAVR. We retrospectively investigated the post-TAVR outcome in super-elderly patients with severe AS. Methods This analysis included 433 patients who underwent TAVR in the University of Wisconsin Hospital and Clinics from 2012 to 2017. Post-TAVR mortality, complications in-hospital, rehospitalization, the New York Heart Association (NYHA) functional class and echocardiographic parameters were compared between patients <85 years old (n = 290) and _85 years old (n = 143). Results The patients _85 years old less frequently had a history of coronary artery disease (73.1% vs. 62.2%, p=0.026) and hypertension (87.2% vs. 77.6%, p=0.012) than younger patients. Furthermore, the patients _85 years old had moderate-severe mitral regurgitation more frequently (19.3% vs. 28.7%, p=0.037) at baseline than younger patients. There was no significant difference in in-hospital outcomes between the age groups. The 30-day mortality was worse in patients _85 years old than in younger ones (0.7% vs. 3.5%, p= 0.042). While there was no significant difference in the long-term mortality between the 2 groups, the estimated 1-year mortality from Kaplan-Meier curves were 9.6% in patients <85 years old and 14.9% in patients _85 years old. The rate of in-hospital complications, rehospitalization rate, improvement in the NYHA functional class and echocardiographic parameters were comparable between the two groups. Conclusion The outcomes of super-elderly patients after TAVR were acceptable, suggesting that these patients could benefit from TAVR.
KW - Severe AS
KW - TAVR
UR - http://www.scopus.com/inward/record.url?scp=85101506376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101506376&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.5047-20
DO - 10.2169/internalmedicine.5047-20
M3 - Article
C2 - 33028765
AN - SCOPUS:85101506376
SN - 0918-2918
VL - 60
SP - 517
EP - 523
JO - Internal Medicine
JF - Internal Medicine
IS - 4
ER -